Development and assessment of antiatherosclerotic therapies beyond low-density lipoprotein cholesterol and blood pressure Christie M. Ballantyne Clinical Trials Review Pages: 281 - 283
Electron beam tomography as an endpoint for clinical trials of antiatherosclerotic therapy Paolo Raggi OriginalPaper Pages: 284 - 289
Percutaneous coronary intervention versus medical therapy for coronary heart disease David J. Maron OriginalPaper Pages: 290 - 296
Hormone replacement therapy in the prevention and treatment of atherosclerosis Lori Mosca OriginalPaper Pages: 297 - 302
Endothelial function as a therapeutic target in coronary artery disease Niraj SharmaThomas C. Andrews OriginalPaper Pages: 303 - 307
Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia Bruce R. Gordon OriginalPaper Pages: 308 - 313
Diet and pharmacologic therapy of obesity to modify atherosclerosis Peter H. Jones OriginalPaper Pages: 314 - 320
Treating ambulatory ischemia in coronary disease by manipulating the cell biology of atherosclerosis James L. OrfordScott KinlayAndrew P. Selwyn OriginalPaper Pages: 321 - 326
Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: Emerging insights for evolving paradigms Jorge Plutzky OriginalPaper Pages: 327 - 335
Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events Joseph B. Muhlestein OriginalPaper Pages: 336 - 341
Antioxidants and vitamins to reduce cardiovascular disease Sridevi DevarajIshwarlal Jialal OriginalPaper Pages: 342 - 351
